Bio Medica Laboratories IPO
Bio Medica Laboratories is an NSE SME IPO is expected to be priced soon with an issue size of 37,72,000 shares(agg. up to ₹[.] Cr). The IPO opens on May 21, 2026 and closes on May 25, 2026, with a lot size is yet to be announced and a minimum investment is yet to be announced.
Bio Medica Laboratories Limited IPO
- IPO Dates
- May 21, 2026 – May 25, 2026
- Price band
- ₹0-0 per equity share
- Minimum Investment
- ₹0
- Issue size
- 37,72,000 shares(agg. up to ₹[.] Cr)
- Lot size
- 0
- Allotment Date
- May 26, 2026
- Listing
- May 29, 2026
- Listing At
- NSE SME
IPO timeline
-
May 21, 2026
Open Date
Upcoming
-
May 25, 2026
Close Date
Upcoming
-
May 26, 2026
Allotment Date
Upcoming
-
May 29, 2026
Listing Date
Upcoming
Bio Medica Laboratories IPO Essentials
Bio Medica Laboratories IPO Details
Bio Medica Laboratories IPO has a total issue size of 37,72,000 shares(agg. up to ₹[.] Cr) and will be listed on NSE SME. Price band & Lot size details are yet to be announced.
- Issue price
- ₹0-0 per equity share
- Lot size
- 0 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 37,72,000 shares(agg. up to ₹[.] Cr)
- Listing at
- NSE SME
- Listing date
- Registrar
- Skyline Financial Services Pvt.Ltd.
- Lead manager
-
Narnolia Financial Services Ltd.
Bio Medica Laboratories IPO Details
- Retail Portion 35%
Bio Medica Laboratories IPO Documents
Bio Medica Laboratories IPO Analytics
Bio Medica Laboratories Valuations
Fundamentals
- Market Cap
- Cr.
Bio Medica Laboratories Financials( In Crs.)
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Assets | 39.12 | 19.53 | 17.57 |
| Revenue | 38.33 | 15.34 | 16.25 |
| Profit After Tax | 9.79 | 2.50 | 0.33 |
| Net Worth | 14.73 | 4.94 | 2.44 |
| Reserves & Surplus | 5.55 | 4.84 | 2.34 |
| Total Borrowing | 15.01 | 10.49 | 9.61 |
Bio Medica Laboratories Company & Offer Insights
About Bio Medica Laboratories
The Bio Medica Laboratories deals in the manufacture of parenteral formulations that involve the development and supply of ethical drug products, generics, and over-the-counter drugs in liquid and dry powder forms for injection purposes.
Product Portfolio:
58 products are present in liquid injectable forms
Dry powder injectable form of products is also supplied with 15 such products
It supplies various types of products like generic drugs, proprietary drugs, over the counter drugs, and others.
Business Model: The Bio Medica Laboratories function as a business to business organization dealing only in contract manufacturing of its products. It develops formulations of different products as per the requirements of various organizations. It is licensed for good manufacturing practices (GMP) and good laboratory practices (GLP) as certified by the Food & Drugs Administration, Madhya Pradesh.
Manufacturing plants: Two plants are located in Indore district of Madhya Pradesh.
Bio Medica Laboratories Promoter(s)
Mr. Mukesh Mehta, Mr. Pradeep Mehta are the company's promoters of Bio Medica Laboratories.
Bio Medica Laboratories IPO Issue Objectives
- •
- Repayment of Loan
- •
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
- •
- General Corporate Purposes
Contact Information
Contact Details
Bio Medica Laboratories
+91 7314102751
companysecretary@biomedica.co.in
Plot No. 11B-11C, Sector-E, Sanwer Road, Industrial Area, Industrial Estate (Indore), Indore, Madhya Pradesh - 452015.
Registrar Contact Details
Skyline Financial Services Private Ltd
02228511022
Frequently Asked Questions
Click any question to reveal the answer
Bio Medica Laboratories IPO is a book-built IPO worth ₹37,72,000 shares(agg. up to ₹[.] Cr). The price band is ₹0–₹0 per share. The IPO opens on May 21, 2026 and closes on May 25, 2026. It will be listed on NSE SME Platform. Skyline Financial Services Pvt. Ltd. is the registrar.
The price band of Bio Medica Laboratories IPO is ₹0 to ₹0 per share.
The lot size of Bio Medica Laboratories IPO is 0 shares.
The minimum investment for Bio Medica Laboratories IPO is not announced yet .
Bio Medica Laboratories IPO opens on May 21, 2026 and closes on May 25, 2026.
The allotment date of Bio Medica Laboratories IPO is May 26, 2026.
Bio Medica Laboratories IPO is expected to be listed on May 29, 2026, on NSE SME Platform.
The Grey market premium (GMP) for Bio Medica Laboratories IPO indicates market sentiment and potential listing expectations based on unofficial trading activity.
Bio Medica Laboratories IPO valuation snapshot: P/E N/A, EPS ₹/-, P/B N/A, RoNW %, and market cap Cr.
To apply for Bio Medica Laboratories IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Bio Medica Laboratories IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Bio Medica Laboratories IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Bio Medica Laboratories IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Bio Medica Laboratories IPO allotment status on IPO Ji for quick and easy access.